Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 109162974 | 10916297 | 4 | F | 20160720 | 20150316 | 20160802 | PER | US-BAYER-2015-035431 | BAYER | 54.00 | YR | A | F | Y | 158.73000 | KG | 20160802 | LW | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 109162974 | 10916297 | 1 | PS | AVELOX | MOXIFLOXACIN HYDROCHLORIDE | 1 | UNK | 21085 | FILM-COATED TABLET | ||||||||||
| 109162974 | 10916297 | 2 | C | REVLIMID | LENALIDOMIDE | 1 | 10 MG, QD | 0 | 10 | MG | QD | ||||||||
| 109162974 | 10916297 | 3 | C | CRESTOR | ROSUVASTATIN CALCIUM | 1 | 40 MG, QD | 0 | 40 | MG | QD | ||||||||
| 109162974 | 10916297 | 4 | C | LASIX | FUROSEMIDE | 1 | 20 MG, BID | 0 | 20 | MG | BID | ||||||||
| 109162974 | 10916297 | 5 | C | Warfarin | WARFARIN | 1 | 7.5 MG, QD | 0 | 7.5 | MG | QD | ||||||||
| 109162974 | 10916297 | 6 | C | AMLODIPINE | AMLODIPINE BESYLATE | 1 | 10 MG, QD | 0 | 10 | MG | QD | ||||||||
| 109162974 | 10916297 | 7 | C | Insulin | INSULIN NOS | 1 | UNK | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 109162974 | 10916297 | 1 | Infection |
| 109162974 | 10916297 | 2 | Plasma cell myeloma |
| 109162974 | 10916297 | 3 | Hypertension |
| 109162974 | 10916297 | 4 | Hypertension |
| 109162974 | 10916297 | 5 | Thrombosis |
| 109162974 | 10916297 | 6 | Hypertension |
| 109162974 | 10916297 | 7 | Diabetes mellitus |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 109162974 | 10916297 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 109162974 | 10916297 | Anxiety | |
| 109162974 | 10916297 | Burning sensation | |
| 109162974 | 10916297 | Cardiovascular disorder | |
| 109162974 | 10916297 | Economic problem | |
| 109162974 | 10916297 | Emotional distress | |
| 109162974 | 10916297 | Fear | |
| 109162974 | 10916297 | Hypoaesthesia | |
| 109162974 | 10916297 | Injury | |
| 109162974 | 10916297 | Mental disorder | |
| 109162974 | 10916297 | Musculoskeletal injury | |
| 109162974 | 10916297 | Nervous system disorder | |
| 109162974 | 10916297 | Neuropathy peripheral | |
| 109162974 | 10916297 | Pain | |
| 109162974 | 10916297 | Paraesthesia | |
| 109162974 | 10916297 | Product quality issue | |
| 109162974 | 10916297 | Quality of life decreased | |
| 109162974 | 10916297 | Skin injury |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 109162974 | 10916297 | 1 | 201102 | 201103 | 0 | |
| 109162974 | 10916297 | 3 | 2006 | 0 | ||
| 109162974 | 10916297 | 7 | 2000 | 0 |